Terizidone (Terivalidin), a derivate of cycloserine (CS), is a bacteriostatic second-line drug for multi-drug-resistant tuberculosis (MDR-TB) in conjunction with other second-line drugs. It is used internationally, but is not currently approved in the United States. It is a combination of two molecules of CS. The MOA includes competitively inhibiting l-alanine racemase and d-alanine ligase to inhibit cell wall synthesis.

纯度：≥98%

CAS：25683-71-0